# A Randomized, Open-label, Two-way Crossover Study to Assess the Pharmacokinetics and Safety of CK-30 600 mg (Compound K)

> **NCT03136770** · NA · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 25 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DIETARY_SUPPLEMENT:** CK-30
- **DIETARY_SUPPLEMENT:** Red ginseng extracts

## Key facts

- **NCT ID:** NCT03136770
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-15
- **Primary completion:** 2017-04-10
- **Final completion:** 2017-04-10
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2017-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03136770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03136770, "A Randomized, Open-label, Two-way Crossover Study to Assess the Pharmacokinetics and Safety of CK-30 600 mg (Compound K)". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03136770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*